Corrigendum to “Increased prevalence of type 2 diabetes mellitus among psychiatric inpatients with bipolar I affective and schizoaffective disorders independent of psychotropic drug use” [J. Affect. Disord. 70 (2002) 19–26]

Regenold, William T.; Thapar, Ramesh K.; Marano, Christopher; Gavirneni, Sridevi; Kondapavuluru, Prasad V.

« Previous Next »Journal of Affective Disorders
Volume 73, Issue 3 , Pages 301-302, February 2003

Corrigendum to “Increased prevalence of type 2 diabetes mellitus among psychiatric inpatients with bipolar I affective and schizoaffective disorders independent of psychotropic drug use”

[J. Affect. Disord. 70 (2002) 19–26]

University of Maryland/Baltimore VAMC Mood Disorders Program, Department of Psychiatry, University of Maryland School of Medicine, Baltimore, MD 21201, USA

Received 7 August 2001; accepted 23 October 2001.

Article Outline

In the above paper the Author regrets that Table 1, Table 2 contained incorrect data. The tables are now reproduced correctly below.

Table 1. Characteristics of 243 Psychiatric Inpatients, Ages 50–74 Years, Grouped by Axis I Diagnosis

Variable	Major		Bipolar		Schizophrenia		Schizoaffective		Dementia		Analysis
	Depression		Disorder				Disorder
	N	%	N	%	N	%	N	%	N	%
Gender											NS
Female	38	59	31	59	46	65	12	60	18	53
Race											NS
Black	23	35	24	45	46	65	11	55	20	59
White	42	65	29	55	25	35	9	45	14	41
Type-2 Diabetes											χ²=14.5, df=4
Diabetic	12	18	14	26	9	13	10	50	6	18	p=0.006
Potentially Hyperglycemic	10	15	12	23	39	55	11	55	3	9	χ²=41.4, df=4
Medication Use^a											p<0.00001
Body Mass (BMI)^b
BMI≥25kg/m²	32	49	31	59	34	48	11	55	12	35	NS
BMI≥30 kg/m²	13	20	16	30	13	18	6	30	3	9	NS
	Mean	SD	Mean	SD	Mean	SD	Mean	SD	Mean	SD	F=6.3, df=4
Age (years)	62.7^c	7.2	60.4	7.2	60.1	6.5	58.8	7.1	66.1^d	6.1	p<0.0001
BMI (kg/m²)	26.0	7.1	27.2	5.0	25.2	5.8	26.7	7.1	23.7	4.3	NS

a Potentially hyperglycemic medications included clozapine, olanzapine, and phenothiazines.

b Overweight is defined as BMI≥25 and <30 kg/m²; Obesity as BMI≥30 kg/m².

c Significantly different (p<0.05) from schizoaffective and schizophrenic groups by post-hoc least significant differences (LSD) test.

d Significantly different (p<0.05) from all other diagnostic groups by (LSD) test.

Table 2. Characteristics of 243 Psychiatric Inpatients, Ages 50–74 Years, Grouped by Diabetes Mellitus Diagnosis

Variable	All Patients		Diabetic		Nondiabetic		Analysis
			Patients		Patients
	N	%	N	%	N	%
Gender							NS
Female	145	60	29	57	116	60
Race							NS
Black	124	51	30	59	94	51
White	119	49	21	41	98	49
Potentially Hyperglycemic							NS
Medication Use^a	75	31	13	26	62	32
Body Mass (BMI)^b
BMI ≥25kg/m²	120	49	33	65	87	45	χ²=6.1, df=1, p=0.01
BMI ≥30 kg/m²	51	21	15	29	36	18	NS
		Mean (SD)	Mean	SD	Mean	SD
Age (years)	243	61.6 (7.1)	61.3	7.7	61.7	7.0	NS
BMI (kg/m²)	243	25.7 (6.0)	28.4	6.6	25.0	5.7	t=3.6, df=241, p=0.001

a Potentially hyperglycemic medications included clozapine, olanzapine, and phenothiazines.

b Overweight is defined as BMI≥25 and <30 kg/m²; Obesity as BMI≥30 kg/m².

PII: S0165-0327(02)00363-4

Refers to article:

Increased prevalence of type 2 diabetes mellitus among psychiatric inpatients with bipolar I affective and schizoaffective disorders independent of psychotropic drug use
William T. Regenold, Ramesh K. Thapar, Christopher Marano, Sridevi Gavirneni, Prasad V. Kondapavuluru
Journal of Affective Disorders June 2002 (Vol. 70, Issue 1, Pages 19-26)